Company Intelligence

HeartFlow

HeartFlow provides enterprise-grade artificial intelligence solutions, delivering specialized HeartFlow Platform technology designed to optimize mission-critical workflows across cardiologists, radiologists, and health systems evaluating stable chest pain without immediate invasive catheterization..

Headquarters
Mountain View, United States
Founded
2010
Status
Public
Products
1
Reports
8
Last reviewed
Aug 2026

Overview

What this company is, what it builds, and who it serves.

HeartFlow is a Healthcare AI company based in Mountain View, United States, founded in 2010.

Public cardiology AI company (Nasdaq: HTFL) analyzing coronary blood flow from CT imaging.

It serves cardiologists, radiologists, and health systems evaluating stable chest pain without immediate invasive catheterization.

Verified founder profile on Brel: John Farquhar.

What it does

The technical focus of HeartFlow is deploying HeartFlow Platform across enterprise environments to resolve data and workflow bottlenecks in Artificial Intelligence for Cardiologists, radiologists, and health systems evaluating stable chest pain without immediate invasive catheterization..

Who it serves

Cardiologists, radiologists, and health systems evaluating stable chest pain without immediate invasive catheterization.

What it builds

HeartFlow Platform

Why It Matters

HeartFlow provides enterprise-grade artificial intelligence solutions, delivering specialized HeartFlow Platform technology designed to optimize mission-critical workflows across cardiologists, radiologists, and health systems evaluating stable chest pain without immediate invasive catheterization..

Products

Products and platforms connected to this company.

Founders

People linked to this company in the Brel founder graph.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

HeartFlow

Industry

Industries served

  • Medical Devices

Capabilities

HeartFlow FFRct Analysis applies deep learning and physics-based modeling to transform CT angiography into personalized flow maps. The AI components handle segmentation…

Features

HeartFlow FFRct Analysis — non-invasive coronary blood flow assessment derived from CT angiography using AI and computational fluid dynamics.

Integrations

The workflow integrates with hospital imaging systems and returns results that cardiologists use alongside clinical judgment, not as autonomous treatment decisions.

Country

United States

Use cases

Official Resources

Official and developer links on file for this company.

Latest Developments

Verified developments and timeline notes on file.

  • Public listing: HeartFlow trades on Nasdaq under ticker HTFL. Latest
  • Company founded 2010 · founded Source
  • Development 2010 · development Source
  • Product 2025 · product Source

Frequently Asked Questions

What does HeartFlow do?

HeartFlow specializes in artificial intelligence, developing HeartFlow Platform to support cardiologists, radiologists, and health systems evaluating stable chest pain without immediate invasive catheterization. with scalable, production-grade technology.

Where is HeartFlow based and when was it founded?

HeartFlow is based in United States and was founded in 2010.

What are the main products offered by HeartFlow?

The flagship platform from HeartFlow is HeartFlow Platform, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of HeartFlow?

HeartFlow primarily serves cardiologists, radiologists, and health systems evaluating stable chest pain without immediate invasive catheterization. seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.